Setback for Millar in Biotech case
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.ANDREW MILLAR, the whistleblower sacked by British Biotech, suffered a setback in his legal fight against the drug development company yesterday when an industrial tribunal turned down his request for an unfair dismissal case.
The tribunal ruled that the High Court case between Dr Millar, former head of clinical research at British Biotech, and the company took precedence over any other proceedings. Dr Millar, who was sacked in April after voicing concerns about two of the company's drugs, had argued that the case should be heard in the tribunal "in the interest of justice". The company had applied for a stay until the end of the High Court case.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments